Arkolith/Insider Trading/VRTX/Form 4

Bhatia Sangeeta N.

DirectorVERTEX PHARMACEUTICALS INC / MA (VRTX) · full profile →Form 4 · filed May 5, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$135K
Net Open-Market Flow
-$135K
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
May 4, 2026Sell(S)318$423.73$135K5K
May 1, 2026Grant(A)943—$05K

Transaction Codes

S
Open-market sale
A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000875320-26-000175) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML